MYC and malignant colon neoplasm: In addition, c-MYC downregulation was reported to lower the proliferation and reduce glucose consumption, lactate production, and ATP production to depress glycolytic metabolism in DLD-1 and SW480 colon cancer cells, which was concordant with our results [40].